Concepedia

Zhensheng Cao

ZC

12

Publications

510

Citations

11

H-Index

1999

Active since

Affiliations

Abbott Fund(Current)

Wenzhou Medical University

First Affiliated Hospital of Wenzhou Medical University

Zhensheng Cao is an author at Abbott Fund specializing in antimicrobial resistance, medicine, and microbiology.

ORCID

Top concepts

Publications per year

1999–2021

12

Publications

12

Novel Erythromycin Derivatives with Aryl Groups Tethered to the C-6 Position Are Potent Protein Synthesis Inhibitors and Active against Multidrug-Resistant Respiratory Pathogens

Zhenkun Ma, Richard F. Clark, Antony Brazzale et al. · Journal of Medicinal Chemistry · 2001 · 112 citations

, , +19

Studies of the Novel Ketolide ABT-773: Transport, Binding to Ribosomes, and Inhibition of Protein Synthesis in <i>Streptococcus pneumoniae</i>

John O. Capobianco, Zhensheng Cao, Virginia D. Shortridge et al. · Antimicrobial Agents and Chemotherapy · 2000 · 84 citations · Full text

Comparison of In Vitro Activities of ABT-773 and Telithromycin against Macrolide-Susceptible and -Resistant Streptococci and Staphylococci

Virginia D. Shortridge, Ping Zhong, Zhensheng Cao et al. · Antimicrobial Agents and Chemotherapy · 2002 · 79 citations · Full text

Induction of Ribosome Methylation in MLS-Resistant <i>Streptococcus pneumoniae</i> by Macrolides and Ketolides

Ping Zhong, Zhensheng Cao, Rachel Hammond et al. · Microbial Drug Resistance · 1999 · 50 citations

A Novel Targeted Therapy System for Cervical Cancer:  Co-Delivery System  of  Antisense LncRNA of MDC1 and Oxaliplatin Magnetic Thermosensitive Cationic Liposome Drug Carrier

Hui Ye, Xiaoying Chu, Zhensheng Cao et al. · International Journal of Nanomedicine · 2021 · 38 citations · Full text

Rows per page

1–5 of 12